TAPI India operates two production sites in north India in Gajraula and Malanpur: The Gajraula (TIG) Site is situated in District J.P. Nagar, Uttar Pradesh, around 105 km from India’s capital city of Delhi.
The site currently has a product list of 40 active pharmaceutical ingredients (APIs) and advanced intermediates including statins, sartans, various cholesterol-lowering agents, and antifungal agents. A large number of scientists, engineers, operating experts and chemists are focused on the adoption of new technologies while carrying out continuous process improvements.
The TIG site has earned approvals from the WHO GMP, the USFDA, the MHRA, the TGA, the AFSSAPS, the KFDA, and the German Ministry of Health, and is regularly audited by leading international bodies and Teva’s business partners.
Teva API India Limited
Plot Nos. A-2, A-2/1 & A-2/2
UPSIDC Industrial Area
Bijnor Road, Distt. J.P. Nagar
Gajraula-244 235 (Uttar Pradesh), India